RNA Binding Protein CUGBP1 Inhibits Liver Cancer in a Phosphorylation-Dependent Manner

Kyle Lewis1,2,3, Leila Valanejad1, Ashley Cast1

  • 1Department of Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Insights

CUGBP1 dephosphorylation at Ser302 activates its translation, promoting liver cancer. Gankyrin targets this form for degradation, a key event in liver cancer development. This study reveals CUGBP1 as a crucial tumor suppressor.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Oncology

Background:

  • Mechanisms underlying liver cancer remain incompletely understood.
  • CUGBP1, an RNA binding protein, has identified tumor suppressor activities.
  • Dephosphorylation at Ser302 activates CUGBP1's translational activity.

Purpose of the Study:

  • To elucidate the role of CUGBP1 phosphorylation in liver cancer.
  • To investigate the mechanism of CUGBP1 neutralization in liver tumorigenesis.
  • To identify factors contributing to the reduction of CUGBP1 in liver cancer.

Main Methods:

  • Generation of CUGBP1-S302A knock-in mice.
  • Diethylnitrosamine (DEN) treatment to induce liver cancer.
  • Investigation of gankyrin (Gank) binding and degradation pathways.
  • Generation of mice with liver-specific deletion of Gank.

Main Results:

  • Reduced translational activity of CUGBP1 leads to fatty liver in S302A mice.
  • DEN-treated S302A mice exhibit more severe liver cancer with CUGBP1 elimination.
  • Gank preferentially binds and degrades dephosphorylated or S302A mutant CUGBP1.
  • Liver-specific Gank deletion protects CUGBP1 from degradation, reducing tumor suppressor loss.

Conclusions:

  • Dephosphorylated CUGBP1 (de-ph-S302-CUGBP1) functions as a tumor suppressor.
  • Gank-induced degradation of CUGBP1 via the ubiquitin-proteasome system (UPS) is critical for liver cancer development.
  • Reduced CUGBP1 levels correlate with liver cancer in both animal models and human pediatric liver cancer patients.

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.7K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K